Chemokine receptor antagonists
Chemokines are chemotactic cytokines, leads to leukocyte recruitment and activation. In malignancies altered expression can induce angiogenesis, tumor cell proliferation, and metastasis. Chemokine receptor antagonists inhibit chemokine receptors expressed on cancer and stromal cells.
Filter by content:
Types
- Newly diagnosed multiple myeloma
- Plasma cell dyscrasias
- Relapsed/refractory multiple myeloma
Therapeutics
- Auto-HSCT
- Bortezomib
- Carfilzomib
- Cyclophosphamide
- Daratumumab
- Dexamethasone
- Immune modulators
- Lenalidomide
- Motixafortide
- Plerixafor
- Proteasome inhibitors
- Thalidomide
Congresses
- ASH 2019
- COMy 2020
- EBMT 2020
Trials
- ALCYONE
- CASSIOPEIA
- GENESIS
- GRIFFIN
- IFM2009
- PERSEUS
- SWOG S0777
Expert Opinions
Educational Resources
- Drug approvals